Find stats on top websites
Larimar Therapeutics' key product feature is their proprietary intracellular delivery platform. This platform is designed to deliver proteins and other molecules directly into cells, which is crucial for treating diseases like Friedreich's ataxia where specific proteins are deficient. Their lead compound, CTI-1601 (nomlabofusp), utilizes this platform to deliver human frataxin, the protein missing in FA patients.
PTC Therapeutics
Reata Pharmaceuticals
Amicus Therapeutics
Larimar Therapeutics' key product feature is their proprietary intracellular delivery platform. This platform is designed to deliver proteins and other molecules directly into cells, which is crucial for treating diseases like Friedreich's ataxia where specific proteins are deficient. Their lead compound, CTI-1601 (nomlabofusp), utilizes this platform to deliver human frataxin, the protein missing in FA patients.
May 15, 2023 ... News; Contact. Contact Us · Directions. About Larimar. Company ... For more information, please visit: https://larimartx.com. Forward ...
View source... top-line Phase 2 dose exploration study data demonstrated nomlabofusp was generally well-tolerated with dose-dependent increases in tissue frataxin levels,.
View sourceFeb 12, 2024 ... News; Contact. Contact Us · Directions. About Larimar. Company ... For more information, please visit: https://larimartx.com. Forward ...
View source... larimartx.com/ (the “Site”). PLEASE REVIEW THIS PRIVACY POLICY CAREFULLY. When you submit information to or through the Site, you consent to the collection ...
View sourceSign up now and unleash the power of AI for your business growth